Opendata, web and dolomites

F-CCW

Functional Cell Culture Ware (F-CCW) : Technical and Commercial feasible?

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 F-CCW project word cloud

Explore the words cloud of the F-CCW project. It provides you a very rough idea of what is the project "F-CCW" about.

grow    goals    transferring    venture    topochip    expensive    upcoming    topography    manufacturing    return    coating    toxicology    moulds    injection    organ    moulding    innovatively    stay    performance    commercial    economic    pharmaceuticals    medical    chemical    ware    manufacturers    pharmaceutical    toxicological    compounds    market    investment    markets    materials    specialists    asian    innovative    dramatically    network    therapies    drug    speed    cells    surface    functionalized    transfer    business    materiomics    generation    plan    industry    topographies    explore    producing    facility    cell    follow    human    contact    demand    culture    investors    breakthrough    create    global    highest    alive    feasibility    throughput    screening    therapeutics    stakeholders    ccw    personalized    invented    creates    multiple    requiring    industries    inlay    marginally    substantially    volume    periods    conventional    medicine    select    efficient    model    designed    limited    laboratories   

Project "F-CCW" data sheet

The following table provides information about the project.

Coordinator
MATERIOMICS BV 

Organization address
address: OXFORDLAAN 70
city: MAASTRICHT
postcode: 6229 EV
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Project website http://www.materiomcs.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
2. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-12-01   to  2016-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MATERIOMICS BV NL (MAASTRICHT) coordinator 50˙000.00

Map

 Project objective

The market for testing of pharmaceuticals and the demand for human cells for cell therapies will grow substantially. Conventional cell culture and organ- model systems (C-CCW) are complex and expensive, due to chemical coating compounds requiring multiple production steps, and marginally effective as cells stay alive for short periods and/or grow at low speed. The performance of cell culture systems and organ model systems can be dramatically improved by using materials with designed surface topography.

Materiomics has invented an innovative TopoChip high-throughput screening technology. The overall aim is to innovatively set up enabling technology to transfer the designed topographies to C-CCW products in a high-volume, low-cost manufacturing process (leading to phase 2 application). It creates the next generation products: Functionalized Cell Culture Ware ( F-CCW )which is simple, highly effective and efficient.

Goals in Phase 1 are to: 1. Demonstrate the technical feasibility of transferring designed topographies on C-CCW 2. Explore commercial feasibility of F-CCW: to develop a business plan. 3. Develop production methods for producing F-CCW 4. Select cell culture system applications that allow for the highest expected economic return on investment. 5. Identify (and contact) network partnerships for creating a production facility for F-CCW’s

Potential end users are research driven industries of drug development, toxicology, personalized medicine and cell therapeutics. Potential stakeholders are investors, injection moulding specialists, manufacturers of moulds for inlay, testing and research laboratories for medical and toxicological testing and pharmaceutical industry. The market is a global market (EU, US and upcoming Asian markets).

F-CCW is a breakthrough in functionality of cell culture. Since F-CCW is not limited to one application only, F-CCW will offer multiple follow-up investment opportunities and create many opportunities for new venture

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "F-CCW" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "F-CCW" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.3.1.;H2020-EU.2.1.2.)

S3D (2015)

Feasibility study to determine the use of ITS technology to replace nuclear density meters in mining, dredging and other areas of hydraulic transport.

Read More  

NANOHIGH (2015)

High volume production facility for high accuracy nanocapsules

Read More  

WORKSHOP4.0 (2016)

Automated real-time production forecasting for industry

Read More